TOP SHIELD Polyurethane Sealant White

Hazard statements (CLP)

H315, H317, H319, H334, H335, H350, H361

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Ingredient(s) with unknown acute toxicity

24.5% (oral), 24.5% (dermal), 1.8% (inhalation)

Signal word

Danger

Hazard statements

Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause respiratory irritation. May cause cancer. Suspected of damaging fertility or the unborn child.

Precautionary statements

General : Read label before use. Keep out of reach of children. If medical advice is needed, have product container or label at hand.

Prevention

Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Wear respiratory protection. Use only outdoors or in a well-ventilated area. Avoid breathing vapor. Wash thoroughly after handling. Contaminated work clothing must not be allowed out of the workplace.

Response

IF exposed or concerned Get medical advice or attention. IF INHALED Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell. If experiencing respiratory symptoms: Call a POISON CENTER or doctor. Take off contaminated clothing and wash it before reuse. Wash contaminated clothing before reuse. IF ON SKIN: Wash with plenty of water. If skin irritation or rash occurs Get medical advice or attention. IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.

Storage

Store locked up. Store in a well-ventilated place. Keep container tightly closed.

Disposal

Dispose of contents and container in accordance with all local, regional, national and international regulations.

Supplemental label elements

WARNING: This product contains chemicals known to the State of California to cause cancer and birth defects or other reproductive harm. Adequate ventilation required when sanding or abrading the dried film. If Adequate ventilation cannot be provided wear an approved particulate respirator (NIOSH approved). Follow respirator manufacturer's directions for respirator use. DELAYED EFFECTS FROM LONG TERM OVEREXPOSURE. Abrading or sanding of the dry film may release Crystalline Silica which has been shown to cause lung damage and cancer under long term exposure. VAPOR AND SPRAY MIST HARMFUL. Gives off harmful vapor of solvents and isocyanates. DO NOT USE IF YOU HAVE CHRONIC (LONG-TERM) LUNG OR BREATHING PROBLEMS, OR IF YOU HAVE EVER HAD A REACTION TO ISOCYANATES. USE ONLY WITH ADEQUATE VENTILATION. WHERE OVERSPRAY IS PRESENT, A POSITIVE PRESSURE AIR SUPPLIED RESPIRATOR (NIOSH approved) SHOULD BE WORN TO PREVENT EXPOSURE. IF UNAVAILABLE, AN APPROPRIATE PROPERLY FITTED APPROVED NIOSH VAPOR/PARTICULATE RESPIRATOR MAY BE EFFECTIVE. Follow directions for respirator use. Wear the respirator for the whole time of spraying and until all vapors and mists are gone. If you have any breathing problems during use, LEAVE THE AREA and get fresh air. If problems remain or happen later, IMMEDIATELY call a doctor - If not available get emergency medical treatment. Have this label with you. Reacts with water in closed container to produce pressure which may cause container to burst. Please refer to the SDS for additional information. Keep out of reach of children. Do not transfer contents to other containers for storage.

2.3 Other hazards

None known.

2.1 Classification of the substance or mixture

SERIOUS EYE DAMAGE/ EYE IRRITATION - Category 2A RESPIRATORY SENSITIZATION - Category 1 SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 1A TOXIC TO REPRODUCTION - Category 2 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Respiratory tract irritation) - Category 3 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 24.5% (oral), 24.5% (dermal), 1.8% (inhalation)